10 results on '"Blood-Aqueous Barrier metabolism"'
Search Results
2. Nanoscale delivery systems in treatment of posterior ocular neovascularization: strategies and potential applications.
- Author
-
Bhatt P, Kelly S, and Sutariya V
- Subjects
- Adenoviridae genetics, Administration, Ophthalmic, Angiogenesis Inhibitors pharmacokinetics, Animals, Blindness etiology, Blindness prevention & control, Blood-Aqueous Barrier metabolism, Blood-Retinal Barrier metabolism, Clinical Trials as Topic, Disease Models, Animal, Genetic Therapy methods, Genetic Vectors administration & dosage, Genetic Vectors genetics, Humans, Laser Therapy methods, Ocular Absorption, Permeability, Photochemotherapy, Retina metabolism, Retinal Neovascularization complications, Treatment Outcome, Vascular Endothelial Growth Factor A antagonists & inhibitors, Vascular Endothelial Growth Factor A genetics, Vision, Low etiology, Vision, Low prevention & control, Vitrectomy, Angiogenesis Inhibitors administration & dosage, Drug Carriers chemistry, Nanoparticles chemistry, Retinal Neovascularization therapy
- Abstract
Pathologic posterior neovascularization of eye is a major cause of irreversible vision loss and limitations of therapeutics to be successfully delivered to back of the eye has been a main obstacle for its effective treatment. Current pharmacological treatment using anti-VEGF agents being delivered intravitreally are effective but complicated due to anatomical and physiological barriers, as well as administration of high and frequent doses. With expanding horizons of nanotechnology, it can be possible to formulate promising nanoscale delivery system to improve penetration and sustained the release of therapeutic in posterior segment of the eye. Taking into consideration advances in the field of nanoscale delivery systems, this special report focuses on emerging strategies and their applications for treatment of posterior ocular neovascularization.
- Published
- 2019
- Full Text
- View/download PDF
3. The Effect of Molecular Weight on Passage of Proteins Through the Blood-Aqueous Barrier.
- Author
-
Ragg S, Key M, Rankin F, and WuDunn D
- Subjects
- Aged, Aged, 80 and over, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Molecular Weight, Proteomics methods, Blood-Aqueous Barrier metabolism, Cataract metabolism, Eye Proteins metabolism
- Abstract
Purpose: To determine the effect of molecular weight (MW) on the concentration of plasma-derived proteins in aqueous humor and to estimate the plasma-derived and eye-derived fractions for each protein., Methods: Aqueous humor and plasma samples were obtained during cataract surgery on an institutional review board-approved protocol. Protein concentrations were determined by ELISA and quantitative antibody microarrays. A total of 93 proteins were studied, with most proteins analyzed using 27 to 116 aqueous and 6 to 30 plasma samples., Results: Plasma proteins without evidence of intraocular expression by sequence tags were used to fit a logarithmic model relating aqueous-plasma ratio (AH:PL) to MW. The log(AH:PL) appears to be well predicted by the log(MW) (P < 0.0001), with smaller proteins such as cystatin C (13 kDa) having a higher AH:PL (1:6) than larger proteins such as albumin (66 kDa, 1:300) and complement component 5 (188 kDa, 1:2500). The logarithmic model was used to calculate the eye-derived intraocular fraction (IOF) for each protein. Based on the IOF, 66 proteins could be categorized as plasma-derived (IOF<20), whereas 10 proteins were primarily derived from eye tissue (IOF >80), and 17 proteins had contribution from both plasma and eye tissue (IOF 20-80)., Conclusions: Protein concentration of plasma-derived proteins in aqueous is nonlinearly dependent on MW in favor of smaller proteins. Our study demonstrates that for proper interpretation of results, proteomic studies evaluating changes in aqueous humor protein levels should take into account the plasma and eye-derived fractions.
- Published
- 2019
- Full Text
- View/download PDF
4. Primary angle closure glaucoma (PACG) susceptibility gene PLEKHA7 encodes a novel Rac1/Cdc42 GAP that modulates cell migration and blood-aqueous barrier function.
- Author
-
Lee MC, Shei W, Chan AS, Chua BT, Goh SR, Chong YF, Hilmy MH, Nongpiur ME, Baskaran M, Khor CC, Aung T, Hunziker W, and Vithana EN
- Subjects
- Blood-Aqueous Barrier metabolism, Carrier Proteins metabolism, Cell Movement genetics, Epithelial Cells metabolism, Genetic Predisposition to Disease, Glaucoma, Angle-Closure metabolism, Glaucoma, Angle-Closure pathology, Humans, Intercellular Junctions metabolism, Iris metabolism, Iris pathology, Polymorphism, Single Nucleotide, Tight Junctions metabolism, cdc42 GTP-Binding Protein metabolism, rac1 GTP-Binding Protein metabolism, Carrier Proteins genetics, Glaucoma, Angle-Closure genetics, cdc42 GTP-Binding Protein genetics, rac1 GTP-Binding Protein genetics
- Abstract
PLEKHA7, a gene recently associated with primary angle closure glaucoma (PACG), encodes an apical junctional protein expressed in components of the blood aqueous barrier (BAB). We found that PLEKHA7 is down-regulated in lens epithelial cells and in iris tissue of PACG patients. PLEKHA7 expression also correlated with the C risk allele of the sentinel SNP rs11024102 with the risk allele carrier groups having significantly reduced PLEKHA7 levels compared to non-risk allele carriers. Silencing of PLEKHA7 in human immortalized non-pigmented ciliary epithelium (h-iNPCE) and primary trabecular meshwork cells, which are intimately linked to BAB and aqueous humor outflow respectively, affected actin cytoskeleton organization. PLEKHA7 specifically interacts with GTP-bound Rac1 and Cdc42, but not RhoA, and the activation status of the two small GTPases is linked to PLEKHA7 expression levels. PLEKHA7 stimulates Rac1 and Cdc42 GTP hydrolysis, without affecting nucleotide exchange, identifying PLEKHA7 as a novel Rac1/Cdc42 GAP. Consistent with the regulatory role of Rac1 and Cdc42 in maintaining the tight junction permeability, silencing of PLEKHA7 compromises the paracellular barrier between h-iNPCE cells. Thus, downregulation of PLEKHA7 in PACG may affect BAB integrity and aqueous humor outflow via its Rac1/Cdc42 GAP activity, thereby contributing to disease etiology., (© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
5. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
- Author
-
Guarnieri G, Zanatta E, Mason P, Scarpa MC, Pigatto E, Maestrelli P, and Cozzi F
- Subjects
- Adult, Biomarkers blood, Blood-Aqueous Barrier metabolism, Blood-Aqueous Barrier pathology, Breath Tests, Capillary Permeability, Carbon Monoxide blood, Case-Control Studies, Female, Hemodynamics, Humans, Hypertension, Pulmonary blood, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary physiopathology, Lung Diseases, Interstitial blood, Lung Diseases, Interstitial diagnosis, Lung Diseases, Interstitial physiopathology, Male, Middle Aged, Nitric Oxide blood, Predictive Value of Tests, Scleroderma, Systemic diagnosis, Spirometry, Hypertension, Pulmonary etiology, Lung physiopathology, Lung Diseases, Interstitial etiology, Pulmonary Diffusing Capacity, Scleroderma, Systemic complications
- Abstract
Objectives: Lung diffusing capacity for carbon monoxide (DLCO) is impaired in interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) associated to systemic sclerosis (SSc), but the mechanism of DLCO reduction remains controversial. We hypothesised that the determinants of DLCO impairment differ in interstitial or vascular involvement of the lung of SSc patients., Methods: DLCO was partitioned into alveolar-capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) using combined single-breath DLNO and DLCO measurements. Seventeen SSc patients without pulmonary involvement (SSc), 20 SSc patients with ILD (SSc-ILD), with and without PAH, and 21 healthy controls were included., Results: DLNO and Dm were reduced in SSc patients as compared with controls, whereas Vc was not significantly different. SSc-ILD patients showed a highly significant decrease in Dm and Vc as compared with SSc patients and controls. Vc tended to be more reduced than Dm in SSc-ILD patients with PAH. Dm and Vc were negatively correlated with PAPs and HCRT scores, but the relationship with the HRCT score was stronger., Conclusions: DLNO is more sensitive than DLCO in detecting functional impairment in SSc without radiologic or haemodynamic alterations. A disproportional reduction of Dm relative to Vc suggests a thickening of the blood-gas diffusion barrier in these patients. In SSc patients with detectable ILD, the gas exchange impairment is due to both components of lung diffusing capacity, and partitioning of DLCO in Dm and Vc is of little use in distinguishing the patients with only ILD from those with ILD complicated by PAH.
- Published
- 2015
6. Death following traumatic brain injury in Drosophila is associated with intestinal barrier dysfunction.
- Author
-
Katzenberger RJ, Chtarbanova S, Rimkus SA, Fischer JA, Kaur G, Seppala JM, Swanson LC, Zajac JE, Ganetzky B, and Wassarman DA
- Subjects
- Animals, Animals, Newborn, Bacterial Load, Blood-Aqueous Barrier metabolism, Blood-Aqueous Barrier physiopathology, Blood-Brain Barrier metabolism, Blood-Brain Barrier physiopathology, Blood-Retinal Barrier metabolism, Blood-Retinal Barrier physiopathology, Brain Injuries metabolism, Brain Injuries mortality, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Disease Models, Animal, Drosophila Proteins metabolism, Drosophila melanogaster genetics, Drosophila melanogaster metabolism, Gene Expression, Glucose administration & dosage, Glucose metabolism, Glucose pharmacology, Hemolymph metabolism, Hemolymph microbiology, Humans, Intestines drug effects, Intestines physiopathology, Reverse Transcriptase Polymerase Chain Reaction, Risk Factors, Survival Rate, Time Factors, Transcription Factors genetics, Transcription Factors metabolism, Brain Injuries genetics, Drosophila Proteins genetics, Intestinal Mucosa metabolism, Polymorphism, Single Nucleotide
- Abstract
Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Unfavorable TBI outcomes result from primary mechanical injuries to the brain and ensuing secondary non-mechanical injuries that are not limited to the brain. Our genome-wide association study of Drosophila melanogaster revealed that the probability of death following TBI is associated with single nucleotide polymorphisms in genes involved in tissue barrier function and glucose homeostasis. We found that TBI causes intestinal and blood-brain barrier dysfunction and that intestinal barrier dysfunction is highly correlated with the probability of death. Furthermore, we found that ingestion of glucose after a primary injury increases the probability of death through a secondary injury mechanism that exacerbates intestinal barrier dysfunction. Our results indicate that natural variation in the probability of death following TBI is due in part to genetic differences that affect intestinal barrier dysfunction.
- Published
- 2015
- Full Text
- View/download PDF
7. Repeated anterior chamber fluorophotometric evaluation of the eyes of ophthalmologically normal dogs.
- Author
-
Miller VS, Allbaugh RA, Roush JK, and Rankin AJ
- Subjects
- Animals, Female, Fluorophotometry veterinary, Male, Models, Biological, Reference Values, Time Factors, Anterior Chamber metabolism, Blood-Aqueous Barrier metabolism, Dogs metabolism, Fluorescein pharmacokinetics, Fluorescent Dyes pharmacokinetics, Fluorophotometry methods
- Abstract
Objective: To perform repeated anterior chamber fluorophotometry on both eyes of ophthalmologically normal dogs to measure fluorescein concentrations over a 5-day period and identify any change in the degree of anterior chamber fluorescence over time or difference between eyes., Animals: 9 healthy adult dogs (18 eyes)., Procedures: Each dog received an IV injection of 10% fluorescein solution, and anterior chamber fluorophotometry was performed 1 hour later on both eyes. This procedure was repeated at the same time each day for 5 consecutive days., Results: A significant increase in fluorescein concentration was evident in the anterior chamber on day 5 in the right eye and days 2, 3, 4, and 5 in the left eye. There was no significant difference in concentration between the left and the right eyes on any day., Conclusions and Clinical Relevance: The increase in ocular fluorescein concentration in the study dogs was unlikely to be of clinical importance and is only pertinent for subsequent research studies. This is a limitation that should be considered when reporting fluorophotometry data as fluorescein concentration or as change in fluorescein concentration from baseline.
- Published
- 2012
- Full Text
- View/download PDF
8. [Mek1 and Mek2 functions in the formation of the blood placental barrier].
- Author
-
Nadeau V, Bissonauth V, and Charron J
- Subjects
- Animals, Blood-Aqueous Barrier metabolism, Blood-Aqueous Barrier physiology, Female, Humans, MAP Kinase Kinase 1 genetics, MAP Kinase Kinase 2 genetics, Mice, Mice, Transgenic, Models, Biological, Placental Circulation physiology, Pregnancy, MAP Kinase Kinase 1 physiology, MAP Kinase Kinase 2 physiology, Placenta metabolism, Placental Circulation genetics
- Abstract
The ERK/MAPK signaling pathway is involved in several cellular functions. Inactivation in mice of genes encoding members of this pathway is often associated with embryonic death resulting from abnormal placental development. The placenta is essential for nutritional and gaseous exchanges between maternal and embryonic circulations, as well as for the removal of metabolic wastes. These exchanges take place without direct contact between the two circulations. In mice, the hematoplacental barrier consists in a triple layer of trophoblast cells and endothelial cells of the embryo. MEK1 and MEK2 are double specificity serine-threonine/tyrosine kinases responsible for the activation of ERK1 and ERK2. Mek1 inactivation results in placental anomalies due to trophoblast cell proliferation and differentiation defects leading to severe delays in the development of placenta and causing the death of the embryo. Although Mek2(-/-) mutant mice survived without any apparent phenotype, double heterozygous Mek1(+/-)Mek2(+/-) mutants die during gestation from placental malformations. Together, these data emphasize the crucial role of the ERK/MAPK cascade in the formation of extraembryonic structures., (© 2012 médecine/sciences – Inserm / SRMS.)
- Published
- 2012
- Full Text
- View/download PDF
9. The effects of anthrax lethal toxin on host barrier function.
- Author
-
Xie T, Auth RD, and Frucht DM
- Subjects
- Animals, Anthrax pathology, Bacillus anthracis metabolism, Bacillus anthracis pathogenicity, Bacterial Toxins pharmacokinetics, Blood-Aqueous Barrier metabolism, Blood-Aqueous Barrier pathology, Endothelium, Vascular metabolism, Endothelium, Vascular pathology, Epithelium metabolism, Epithelium pathology, Host-Pathogen Interactions, Humans, Intestinal Mucosa metabolism, Intestines drug effects, Intestines microbiology, Intestines pathology, Lung drug effects, Lung metabolism, Lung microbiology, Lung pathology, Anthrax microbiology, Antigens, Bacterial toxicity, Bacterial Toxins toxicity, Blood-Aqueous Barrier drug effects, Endothelium, Vascular drug effects, Epithelium drug effects
- Abstract
The pathological actions of anthrax toxin require the activities of its edema factor (EF) and lethal factor (LF) enzyme components, which gain intracellular access via its receptor-binding component, protective antigen (PA). LF is a metalloproteinase with specificity for selected mitogen-activated protein kinase kinases (MKKs), but its activity is not directly lethal to many types of primary and transformed cells in vitro. Nevertheless, in vivo treatment of several animal species with the combination of LF and PA (termed lethal toxin or LT) leads to morbidity and mortality, suggesting that LT-dependent toxicity is mediated by cellular interactions between host cells. Decades of research have revealed that a central hallmark of this toxicity is the disruption of key cellular barriers required to maintain homeostasis. This review will focus on the current understanding of the effects of LT on barrier function, highlighting recent progress in establishing the molecular mechanisms underlying these effects.
- Published
- 2011
- Full Text
- View/download PDF
10. Alterations in the aqueous humor proteome in patients with a glaucoma shunt device.
- Author
-
Anshu A, Price MO, Richardson MR, Segu ZM, Lai X, Yoder MC, and Price FW Jr
- Subjects
- Adult, Aged, Aqueous Humor chemistry, Blood-Aqueous Barrier pathology, Case-Control Studies, Cataract complications, Cataract pathology, Cataract Extraction, Chromatography, Liquid, Female, Glaucoma complications, Glaucoma pathology, Glaucoma surgery, Humans, Lens, Crystalline pathology, Lens, Crystalline surgery, Male, Middle Aged, Protein Transport drug effects, Tandem Mass Spectrometry, Aqueous Humor metabolism, Blood Proteins analysis, Blood-Aqueous Barrier metabolism, Cataract metabolism, Glaucoma metabolism, Glaucoma Drainage Implants adverse effects, Lens, Crystalline metabolism, Proteome analysis
- Abstract
Purpose: To investigate whether implantation of a glaucoma shunt device leads to inappropriate accumulation of plasma derived proteins in the aqueous humor., Methods: Aqueous humor samples were collected from 11 patients (study group) with a glaucoma shunt device undergoing either cataract surgery or a corneal transplant and 11 patients (control) with senile cataract undergoing routine cataract extraction. Of the study group, 9 had an Ahmed valve implant and 2 eyes had a Baerveldt implant. Tryptic digests of the mixture of proteins in aqueous humor (AH) were analyzed using Liquid Chromatography/Mass Spectrometry (LC-MS/MS). Proteins were identified with high confidence using stringent criteria and compared quantitatively using a label-free platform (IdentiQuantXL™)., Results: We identified 135 proteins in the albumin-depleted fraction in both the study and control group AH. Using stringent criteria, 13 proteins were detected at a significantly higher level compared to controls. These proteins are known to play a role in oxidative stress, apoptosis, inflammation and/or immunity and include gelsolin (p=0.00005), plasminogen (p=0.00009), angiotensinogen (p=0.0001), apolipoprotein A-II (p=0.0002), beta-2-microglobulin (p=0.0002), dickkopf-3 (DKK-3; p=0.0002), pigment epithelium-derived factor (p=0.0002), RIG-like 7-1 (p=0.0002), afamin (p=0.0003), fibronectin 1 (FN1; p=0.0003), apolipoprotein A-I (p=0.0004), activated complement C4 protein (C4a; p=0.0004) and prothrombin (p=0.0004). Many of the identified proteins were novel proteins that have not been associated with glaucoma in prior studies. All but C4a (complement C4 is a plasma protein but not in an activated form) are known plasma proteins and the elevated levels of these proteins in the aqueous humor suggests a breach in the blood-aqueous barrier with passive influx into the anterior chamber of the eye., Conclusions: The presence of these proteins in the aqueous humor suggests that glaucoma shunt device causes either a breach in blood-aqueous barrier or chronic trauma, increasing influx of oxidative, apoptotic and inflammatory proteins that could potentially cause corneal endothelial damage.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.